In MCF-7 (ER positive) and MDA-MB-231 (TN) breast cancer cells, rosemary extract decreased cell viability in a dose-dependent manner, with an IC50 value of 20.42 μg /mL [59]. This evidence concerns the gene ESR1 and breast carcinoma.